Cita APA (7a ed.)

KA, R., H, L., W, W., L, H., S, A., A, S., . . . B, N. (2014). Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity. Dove Medical Press.

Cita Chicago Style (17a ed.)

KA, Ross, et al. Hemagglutinin-based Polyanhydride Nanovaccines Against H5N1 Influenza Elicit Protective Virus Neutralizing Titers and Cell-mediated Immunity. Dove Medical Press, 2014.

Cita MLA (8a ed.)

KA, Ross, et al. Hemagglutinin-based Polyanhydride Nanovaccines Against H5N1 Influenza Elicit Protective Virus Neutralizing Titers and Cell-mediated Immunity. Dove Medical Press, 2014.